...Gérard Waeber; Fulgencio Gomez; Angelika Bishof-Delaloye; Pascal Chaubert; Marie-Louise Francke; Jacques-Antoine Haefliger; Urs Scherrer; Gabriel Centeno; Evelyne Temler; Pascal Nicod A sporadic case of multiple endocrine neoplasia type I with coexisting insulinoma and hyperparathyroidism...

... diabetes mellitus in transgenic mice. Human insulin gene Insulin gene regulation Insulinoma Diabetes MHC I MHC II © 1989 S. Karger AG, Basel 1989 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages...

... and thereafter when the tumor cannot be found or is metastatic. Its efficacy depends upon the tumor type and probably the presence of somatostatin receptors on the tumoral cells. It could decrease with time, especially in VIPomas. Side effects are few and usually mild. Hypoglycemia attacks in insulinoma could...

...P.R. Flatt; K.S. Tan; S.K. Swanston-Flatt; C.J. Bailey; V. Marks Subcutaneous implantation of small fragments of a radiation-induced transplantable rat insulinoma into the subscapular region of 16- to 17-week-old male NEDH rats resulted, over a 22-day period, in the progressive development...

...S.W.J. Lamberts Experience with SMS 201-995 (Sandostatin), a somatostatin analog, in the treatment of endocrine active gastrointestinal tumors is reviewed. Best immediate results were obtained in vipomas and insulinomas but a scape phenomenon was frequently observed. A positive and persistent...

...P.R. Hearn; M. Ahmed; N.J.Y. Woodhouse A 76-year-old man, a known case of insulinoma, was well controlled for 11 days on 50 µg SMS 201-995 every 12 h; clinical recovery was immediate with normalization of blood sugars and C-peptide levels. The potential value of this new drug in the management...

...Stefano Romeo; Massimo Milione; Alessandra Gatti; Mara Fallarino; Vito Corleto; Susanna Morano; Marco Giorgio Baroni Insulinoma is the most common pancreatic endocrine tumor, accounting for 40% of all pancreatic functional neoplasm, and is characterized by hypersecretion of insulin and hypoglycemia...